DENVER, Dec. 8, 2006 (PRIME NEWSWIRE) -- The law firm of Shuman & Berens LLP (www.shumanberens.com) today encouraged persons who currently own the common stock of Pediatrix Medical Group (NYSE:PDX) to contact Kip B. Shuman of Shuman & Berens LLP at 1-800-711-6483 or via email at kip@shumanberens.com, concerning their rights and interests regarding possible stock option backdating at the company.
Shuman & Berens LLP is investigating potentially improper backdating of Pediatrix Medical Group stock options granted to company employees. On December 6, 2006, the company announced that it estimates that it may have to recognize additional compensation expense of about $28 million, in the aggregate, on a pretax basis for the 1995 through 2005 time period as a result of deficiencies in its stock option granting process. In addition, Mr. Lawrence Mullen, who has served as the company's CFO and CEO, resigned from the board. Mr. Mullen had a significant role in the administration of the company's stock options program
For a free consultation regarding your rights and interests with respect to your Pediatrix Medical Group stockholdings, you may contact Kip B. Shuman of Shuman & Berens LLP at 1-800-711-6483, or via email at kip@shumanberens.com.
Shuman & Berens LLP's attorneys have extensive experience in prosecuting shareholder litigation and have played significant roles in securities actions throughout the nation. For more information about Shuman & Berens LLP go to www.shumanberens.com.